// App-Quantinova.ai

3027 : Phase I trial of chloroquine (CQ)/hydroxychloroquine (HCQ) in combination with carboplatin-gemcitabine (CG)in patients with advanced solid tumors.

Researchers

Presenter

  • Nagla Fawzy Abdel Karim

Principal Investigators

  • Imran Ahmad

  • Ola Gaber

  • Ihab Eldessouki

  • Olugbenga Olanrele Olowokure

  • Maria Farooq

  • John Charles Morris

Medical Centers

  • University of Cincinnati, Cincinnati, OH

  • Augusta University, Augusta, GA

  • University of Central Florida, Orlando, FL

  • University of Cincinnati Cancer Institute, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Carboplatin

  • chloroquine

  • Gemcitabine

Outcome

  • N/A

Study Design

  • Controlled

  • Dose Escalation

  • Cohort

Phase

  • I

Study Id's

  • NCT02071537

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved